Real-world evidence supporting Tandem Control-IQ hybrid closed-loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations

Authors

Gregory P Forlenza, University of Colorado
Anders L Carlson, HealthPartners Institute
Rodolfo J Galindo, Emory University
Davida F Kruger, Henry Ford Health System
Carol J Levy, Mount Sinai School of Medicine
Janet B McGill, Washington University School of Medicine in St. Louis
Guillermo Umpierrez, Emory University
Grazia Aleppo, Northwestern University

Journal

Diabetes Technology & Therapeutics

Publication Date

11-1-2022

Volume

24

Issue

11

First Page

814

Last Page

823

Document Type

Open Access Publication

DOI

10.1089/dia.2022.0206

Rights and Permissions

Forlenza GP, Carlson AL, Galindo RJ, Kruger DF, Levy CJ, McGill JB, Umpierrez G, Aleppo G. Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations. Diabetes Technol Ther. 2022 Nov;24(11):814-823. doi: 10.1089/dia.2022.0206. This Open Access article is distributed under the terms of the Creative Commons License ( http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

Recommended Citation

Forlenza, Gregory P; Carlson, Anders L; Galindo, Rodolfo J; Kruger, Davida F; Levy, Carol J; McGill, Janet B; Umpierrez, Guillermo; and Aleppo, Grazia, "Real-world evidence supporting Tandem Control-IQ hybrid closed-loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations." Diabetes Technology & Therapeutics. 24, 11. 814 - 823. (2022).
https://digitalcommons.wustl.edu/oa_4/972